Menu
Back to User profile » Professor James F Donohue
Papers published by Professor James F Donohue:
Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD
Donohue JF, Rheault T, MacDonald-Berko M, Bengtsson T, Rickard K
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1611-1622
Published Date: 28 July 2023
Bridging the “Know-Do” Gaps in Five Non-Communicable Diseases Using a Common Framework Driven by Implementation Science
Donohue JF, Elborn JS, Lansberg P, Javed A, Tesfaye S, Rugo H, Duddi SRD, Jithoo N, Huang PH, Subramaniam K, Ramanjinappa N, Koltun A, Melamed S, Chan JCN
Journal of Healthcare Leadership 2023, 15:103-119
Published Date: 3 July 2023
The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies [Corrigendum]
Donohue JF, Ozol-Godfrey A, Goodin T, Sanjar S
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1177-1178
Published Date: 26 May 2020
The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies
Donohue JF, Ozol-Godfrey A, Goodin T, Sanjar S
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:745-754
Published Date: 14 April 2020
Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD
Donohue JF, Mahler DA, Sethi S
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2947-2958
Published Date: 19 December 2019
An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD
Singh D, D'Urzo AD, Donohue JF, Kerwin EM, Molins E, Chuecos F, Ribera A, Jarreta D
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2835-2848
Published Date: 6 December 2019
Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD
Ghosh S, Pleasants RA, Ohar JA, Donohue JF, Drummond MB
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:585-595
Published Date: 1 March 2019
Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT
D'Urzo AD, Singh D, Donohue JF, Kerwin EM, Ribera A, Molins E, Chuecos F, Jarreta D, Garcia Gil E
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:479-491
Published Date: 26 February 2019
Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial
Donohue JF, Bollu VK, Stull DE, Nelson LM, Williams VSL, Stensland MD, Hanania NA
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:499-508
Published Date: 5 February 2018
Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis
Donohue JF, Betts KA, Du EX, Altman P, Goyal P, Keininger DL, Gruenberger JB, Signorovitch JE
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:367-381
Published Date: 19 January 2017
Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA
Cohen J, Miles MC, Donohue JF, Ohar JA
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:785-797
Published Date: 15 April 2016
Systematic review comparing LABA, olodaterol, and indacaterol: limitations
Donohue JF
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:1331-1335
Published Date: 5 December 2014
Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study
Donohue JF, Herje N, Crater G, Rickard K
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:745-751
Published Date: 16 July 2014
Considerations for managing chronic obstructive pulmonary disease in the elderly
Taffet GE, Donohue JF, Altman PR
Clinical Interventions in Aging 2014, 9:23-30
Published Date: 13 December 2013
Safety of indacaterol in the treatment of patients with COPD
Donohue JF, Singh D, Kornmann O, Lawrence D, Lassen C, Kramer B
International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:477-492
Published Date: 22 September 2011